Pea hull fiber supplementation does not modulate uremic metabolites in adults receiving hemodialysis: a randomized, double-blind, controlled trial
- PMID: 37457968
- PMCID: PMC10349378
- DOI: 10.3389/fnut.2023.1179295
Pea hull fiber supplementation does not modulate uremic metabolites in adults receiving hemodialysis: a randomized, double-blind, controlled trial
Abstract
Background: Fiber is a potential therapeutic to suppress microbiota-generated uremic molecules. This study aimed to determine if fiber supplementation decreased serum levels of uremic molecules through the modulation of gut microbiota in adults undergoing hemodialysis.
Methods: A randomized, double-blinded, controlled crossover study was conducted. Following a 1-week baseline, participants consumed muffins with added pea hull fiber (PHF) (15 g/d) and control muffins daily, each for 4 weeks, separated by a 4-week washout. Blood and stool samples were collected per period. Serum p-cresyl sulfate (PCS), indoxyl sulfate (IS), phenylacetylglutamine (PAG), and trimethylamine N-oxide (TMAO) were quantified by LC-MS/MS, and fecal microbiota profiled by 16S rRNA gene amplicon sequencing and specific taxa of interest by qPCR. QIIME 2 sample-classifier was used to discover unique microbiota profiles due to the consumption of PHF.
Results: Intake of PHF contributed an additional 9 g/d of dietary fiber to the subjects' diet due to compliance. No significant changes from baseline were observed in serum PCS, IS, PAG, or TMAO, or for the relative quantification of Akkermansia muciniphila, Faecalibacterium prausnitzii, Bifidobacterium, or Roseburia, taxa considered health-enhancing. Dietary protein intake and IS (r = -0.5, p = 0.05) and slow transit stool form and PCS (r = 0.7, p < 0.01) were significantly correlated at baseline. PHF and control periods were not differentiated; however, using machine learning, taxa most distinguishing the microbiota composition during the PHF periods compared to usual diet alone were enriched Gemmiger, Collinsella, and depleted Lactobacillus, Ruminococcus, Coprococcus, and Mogibacteriaceae.
Conclusion: PHF supplementation did not mitigate serum levels of targeted microbial-generated uremic molecules. Given the high cellulose content, which may be resistant to fermentation, PHF may not exert sufficient effects on microbiota composition to modulate its activity at the dose consumed.
Keywords: dietary protein; fiber; hemodialysis; indoxyl sulfate; microbiota; p-cresyl sulfate; stool form; uremia.
Copyright © 2023 Fatani, Suh, Auger, Alabasi, Wang, Segal and Dahl.
Conflict of interest statement
Author JA, employed with Lallemand Health Solutions Inc., assisted with the analysis and interpretation of the microbiota data and in writing the microbiota methods and results. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Gastrointestinal Tolerance and Microbiome Response to Snacks Fortified with Pea Hull Fiber: A Randomized Trial in Older Adults.Curr Dev Nutr. 2020 Jan 17;4(2):nzaa005. doi: 10.1093/cdn/nzaa005. eCollection 2020 Feb. Curr Dev Nutr. 2020. PMID: 32025615 Free PMC article.
-
Effect of Dietary Inulin Supplementation on the Gut Microbiota Composition and Derived Metabolites of Individuals Undergoing Hemodialysis: A Pilot Study.J Ren Nutr. 2021 Sep;31(5):512-522. doi: 10.1053/j.jrn.2020.10.003. Epub 2021 Jun 11. J Ren Nutr. 2021. PMID: 34120835 Free PMC article. Clinical Trial.
-
In older women, a high-protein diet including animal-sourced foods did not impact serum levels and urinary excretion of trimethylamine-N-oxide.Nutr Res. 2020 Jun;78:72-81. doi: 10.1016/j.nutres.2020.05.004. Epub 2020 May 17. Nutr Res. 2020. PMID: 32544852 Clinical Trial.
-
Associations Among Plant-Based Diet Quality, Uremic Toxins, and Gut Microbiota Profile in Adults Undergoing Hemodialysis Therapy.J Ren Nutr. 2021 Mar;31(2):177-188. doi: 10.1053/j.jrn.2020.07.008. Epub 2020 Sep 25. J Ren Nutr. 2021. PMID: 32981834 Clinical Trial.
-
The Influence of Prebiotic Arabinoxylan Oligosaccharides on Microbiota Derived Uremic Retention Solutes in Patients with Chronic Kidney Disease: A Randomized Controlled Trial.PLoS One. 2016 Apr 21;11(4):e0153893. doi: 10.1371/journal.pone.0153893. eCollection 2016. PLoS One. 2016. PMID: 27100399 Free PMC article. Clinical Trial.
Cited by
-
Gut microbiota-dependent phenylacetylglutamine in cardiovascular disease: current knowledge and new insights.Front Med. 2024 Feb;18(1):31-45. doi: 10.1007/s11684-024-1055-9. Epub 2024 Mar 1. Front Med. 2024. PMID: 38424375 Review.
-
Gut Microbiota in Patients Receiving Dialysis: A Review.Pathogens. 2024 Sep 15;13(9):801. doi: 10.3390/pathogens13090801. Pathogens. 2024. PMID: 39338992 Free PMC article. Review.
References
-
- Rossi M, Johnson DW, Xu H, Carrero JJ, Pascoe E, French C, et al. . Dietary protein-fiber ratio associates with circulating levels of indoxyl sulfate and p-cresyl sulfate in chronic kidney disease patients. Nutr Metab Cardiovasc Dis. (2015) 25:860–5. doi: 10.1016/j.numecd.2015.03.015, PMID: - DOI - PubMed
LinkOut - more resources
Full Text Sources